Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Substitution Language In E-Health Record Regs Concerns PhRMA

Executive Summary

The Pharmaceutical Research and Manufacturers of America and drug manufacturers offer comments on HHS’ proposed next-stage requirements for electronic health records, which physicians and hospitals will have to meet in order to qualify for incentive payments for the meaningful use of EHRs.

You may also be interested in...



PhRMA Wants Medication Adherence Coalition To Address Communication Restrictions

At the Council for Affordable Health Coverage’s event to launch its Prescription for Healthy America campaign, PhRMA President and CEO John Castellani says opening up the ability of drug manufacturers to communicate about their products could help improve medication adherence.

EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock

FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.

Adoption Of E-Health Records Gets Stimulus Of Medicare Rewards, Penalties

A program to bring about wider adoption of health information technology in physicians' offices is mirroring the conceptual framework of rewarding and penalizing physicians through Medicare payments that was used to promote adoption of electronic prescribing

Topics

Related Companies

UsernamePublicRestriction

Register

PS055067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel